Table 1.
Genotype distribution of the four pharmacogenetics variants in the Greek-Cypriot population
|
VKORC1
-1639AG |
CYP2C9
|
CYP2C9
|
CYP3A5
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | AA | AG | GG | *1/*1 | *1/*2 | *2/*2 | *1/*1 | *1/*3 | *3/*3 | *1/*1 | *1/*3 | *3/*3 |
148 |
44 |
70 |
34 |
107 |
34 |
7 |
115 |
33 |
0 |
0 |
17 |
131 |
100 | 29.7% | 47.3% | 23.0% | 72.3% | 23.0% | 4.7% | 77.7% | 22.3% | 0% | 0% | 11.5% | 88.5% |